{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:46:37Z","timestamp":1793918797683,"version":"4.8.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jdcr.2021.02.018","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T12:22:56Z","timestamp":1614687776000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II\u2013induced cutaneous inflammation"],"prefix":"10.1016","volume":"10","author":[{"given":"Girish Gilly","family":"Munavalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Knutsen-Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary P.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy G.","family":"Geronemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2021.02.018_bib1","first-page":"1","article-title":"COVID-19\/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment","author":"Munavalli","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jdcr.2021.02.018_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijwd.2021.01.007","article-title":"The art of prevention: COVID-19 vaccine preparedness for the dermatologist","author":"Rice","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"8","key":"10.1016\/j.jdcr.2021.02.018_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/DSS.0000000000000418","article-title":"Delayed-onset nodules secondary to a smooth cohesive 20mg\/ml hyaluronic acid filler: cause and management","volume":"41","author":"Beleznay","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jdcr.2021.02.018_bib4","doi-asserted-by":"crossref","first-page":"e14644","DOI":"10.1111\/dth.14644","article-title":"Increased risk of late-onset, immune-mediated, adverse reactions related to dermal fillers in patients bearing HLA-B\u221708 and DRB1\u221703 haplotypes","volume":"34","author":"Decates","year":"2021","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.jdcr.2021.02.018_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/exd.14159","article-title":"The role of the renin-angiotensin system in skin physiology and pathophysiology","volume":"29","author":"Silva","year":"2020","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2021.02.018_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.0906-6705.2004.0139.x","article-title":"Human skin: source of and target organ for angiotensin II","volume":"13","author":"Steckelings","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdcr.2021.02.018_bib7","doi-asserted-by":"crossref","first-page":"118075","DOI":"10.1016\/j.lfs.2020.118075","article-title":"The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions","volume":"257","author":"Behl","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.jdcr.2021.02.018_bib8","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1038\/s41467-020-18319-6","article-title":"Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jdcr.2021.02.018_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/v12050491","article-title":"ACE2: the key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel?","volume":"12","author":"Xiao","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.jdcr.2021.02.018_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.dsx.2020.05.022","article-title":"Angiotensin converting enzyme-2 as therapeutic target in COVID-19","volume":"14","author":"Roshanravan","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"10.1016\/j.jdcr.2021.02.018_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1253\/circj.CJ-12-1544","article-title":"Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases","volume":"77","author":"Kuba","year":"2013","journal-title":"Circ J"},{"issue":"10","key":"10.1016\/j.jdcr.2021.02.018_bib12","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.bbadis.2019.07.006","article-title":"Critical role of the endogenous renin-angiotensin system in maintaining self-renewal and regeneration potential of epidermal stem cells","volume":"1865","author":"Liao","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"10.1016\/j.jdcr.2021.02.018_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cei.12467","article-title":"Angiotensin II in inflammation, immunity and rheumatoid arthritis","volume":"179","author":"Chang","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jdcr.2021.02.018_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fimmu.2015.00210","article-title":"The hyaluronic acid-HDAC3-miRNA network in allergic inflammation","volume":"6","author":"Kim","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jdcr.2021.02.018_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fimmu.2016.00039","article-title":"Editorial: Interaction between hyaluronic acid and its receptors (CD44, RHAMM) regulates the activity of inflammation and cancer","volume":"7","author":"Naor","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jdcr.2021.02.018_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12016-012-8348-5","article-title":"Late-onset inflammatory adverse reactions related to soft tissue filler injections","volume":"45","author":"Alijotas-Reig","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jdcr.2021.02.018_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/CCID.S247171","article-title":"Delayed inflammatory reactions to hyaluronic acid fillers: a literature review and proposed treatment algorithm","volume":"13","author":"Artzi","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jdcr.2021.02.018_bib18","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.4049\/jimmunol.170.7.3866","article-title":"Modulation of cutaneous inflammation by angiotensin-converting enzyme","volume":"170","author":"Scholzen","year":"2003","journal-title":"J Immunol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621001375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621001375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:52Z","timestamp":1762474972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512621001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":18,"alternative-id":["S2352512621001375"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.02.018","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II\u2013induced cutaneous inflammation","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}